An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.

Sharma, Shilpi; Lewinski, Mary K; Guatelli, John

Sharma, Shilpi; Lewinski, Mary K; Guatelli, John.

Affiliation

Sharma S; Department of Medicine, University of California-San Diego, La Jolla, California, USA ssharma@vapop.ucsd.edu jguatelli@ucsd.edu.
Lewinski MK; Department of Medicine, University of California-San Diego, La Jolla, California, USA.
Guatelli J; VA San Diego Healthcare System, San Diego, California, USA.

J Virol ; 92(22)2018 11 15.

Article in En | MEDLINE | ID: mdl-30158294

Subject(s)

HIV-1/growth & development; Host-Pathogen Interactions/physiology; Membrane Proteins/genetics; Membrane Proteins/metabolism; nef Gene Products, Human Immunodeficiency Virus/metabolism; Cell Line; Cell Membrane/metabolism; Glycosylation; HEK293 Cells; HIV-1/genetics; Humans; Leupeptins/pharmacology; Lysosomes/drug effects; Macrolides/pharmacology; Polysaccharides/chemistry; Proteasome Inhibitors/pharmacology

Key words

Nef; SERINC5; glycosylation; human immunodeficiency virus

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV-1 / Nef Gene Products, Human Immunodeficiency Virus / Host-Pathogen Interactions / Membrane Proteins Limits: Humans Language: En Journal: J Virol Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google